Bilateral Anterior Toxic Optic Neuropathy and the Use of Infliximab
BMJ 326:579, ten Tusscher,M.P.M.,et al, 2003

Neurological Aspects of Taste Disorders
Arch Neurol 60: 667-671, Heckmann,J.G.,et al, 2003

Management of Drug and Alcohol Withdrawal
NEJM 348:1786-1795, Kosten,T.R. &O'Connor,P.G., 2003

West Nile Encephalitis
BMJ 326:865-869, Solomon,T.,et al, 2003

Evidence for Widespread Axonal Damage at the Earliest Clinical Stage of Multiple Sclerosis
Brain 126:433-437, Filippi,M.,et al, 2003

Guidelines for the Early Management of Patients with Ischemic Stroke
Stroke 34:1056-1083, Adams,H.P.,et al, 2003

Stereotactic Treatment of Intracerebral Hematoma by Means of a Plasminogen Activator
Stroke 34:968-974, Teernstra,O.P.M.,et al, 2003

Cuahoga County Operation Stroke Speed of Emergency Department Evaluation and Compliance with National Institutes of Neurological Disorders and Stroke Time Targets
Stroke 34:994-998, Katzan,I.L.,et al, 2003

Statin-Associated Myopathy
JAMA 289:1681-1690, Thompson,P.D.,et al, 2003

Doxycycline Induced Intracranial Hypertension
BMJ 326:641-642,613, Lochhead,J. &Elston,J.S., 2003

Apoptosis and Caspases in Neurodegenerative Diseases
NEJM 348:1365-1375, Friedlander,R.M., 2003

Frequency of Thrombolytic Therapy in Patients With Acute Ischemic Stroke and the Risk of In-Hospital Mortality
Stroke 34:1106-1113, Heuschmann,P.U.,et al, 2003

Pre- and In-Hospital Delays From Stroke Onset to Intra-arterial Thrombolysis
Stroke 34:1230-1234, Nedeltchev,K.,et al, 2003

Effects of Admission Hyperglycemia on Stroke Outcome in Reperfused Tissue Plasminogen Activator-Treated Patients
Stroke 34:1235-1241, Alvarez-Sabin,J.,et al, 2003

Hemi-orolingual Angioedema and ACE Inhibition After Alteplase Treatment of Stroke
Neurol 60:1525-1527,1403, Hill,M.D.,et al, 2003

Diffusion-Weighted MR Findings in Isolated Angilitis of the Central Nervous System (IACNS)
Acta Neurol Scand 108:346-351, Lee, S.-Y.,et al, 2003

Glioblastoma in Kidney Transplant Recipients. Report of Five Cases
J Neurooncol 63:33-37, Salvati,M.,et al, 2003

Carbon Monoxide Poisoning and Sensorineural Hearing Loss
J Laryngol Otol 117:134-137, Hassan,M.S.,et al, 2003

Cerebral Toxoplasmosis Following Etanercept Treatment for Idiophatic Pneumonia Syndrome after Autologous Peripheral Blood Progenitor Cell Transplantation (PBPCT)
Ann Hematol 82:649-653, Gonzalez-Vicent, M.,et al, 2003

Reversible Postictal MRI Change Mimicking Structural Lesion
Clin Neurol Neurosurg 105:288-290, Hicdonmez, T.,et al, 2003

Serial Proton MR Spectroscopy and Diffusion Imaging Findings in HIV-Related Herpes Simplex Encephalitis
AJNR 24:2015-2019, S�mann,P.G., et al, 2003

Disease-Modifying Therapy in Multiple Sclerosis: Strategies for Optimizing Management
The Neurologist 8:227-236, Frohman,E.,et al, 2002

Thalidomide-Induced Neuropathy
Neurol 59:1872-1875, Chaudhry,V.,et al, 2002

A Case Suspected of Acute Gas Poisoning by Carbon Monoxide (CO), Presenting with Progressive Diffuse Leukoencephalopathy Associated with Marked Brain Edema
No To Shinkei 54:493-497, Akaiwa,Y.,et al, 2002

Reversible Metronidazole-Induced Lesions of the Cerebellar Dentate Nuclei
NEJM 346:68-69, Woodruff,B.K.,et al, 2002

Steroid Treatment for Myasthenia Gravis
Muscle Nerve 25:115-121, Rivner,M.H., 2002

An Open-Label Trial of Combination Therapy With Interferon B-1a and Oral Methotrexate in MS
Neurol 58:314-317, Calabresi,P.A.,et al, 2002

Disease Modifying Therapies in Multiple Sclerosis
Neurol 58:169-178, Goodin,D.S.,et al, 2002

Recombinant Interferon-a-induced Chorea and Frontal Subcortical Dementia
Neurol 58:328-330, Moulignier,A.,et al, 2002

Magnetic Resonance Imaging Detection of Microbleeds Before Thrombolysis
Stroke 33:95-98, Kidwell,C.S.,et al, 2002

Clinical and Sonographic Patterns of Tandem Internal Carotid Artery/Middle Cerebral Artery Occlusion in Tissue Plasminogen Activator-Treated Patients
Stroke 33:99-102, El-Mitwalli,A.,et al, 2002

Acute Intravenou-Intra-Arterial Revascularization Therapy for Severe Ischemic Stroke
Stroke 33:279-282, Hill,M.D.,et al, 2002

Cerebral Vasoconstriction and Stroke After Use of Serotonergic Drugs
Neurol 58:130-133, Singhal,A.B.,et al, 2002

Thrombolysis in Stroke Beyond Three Hours: Targeting Patients With Diffusion and Perfusion MRI
Ann Neurol 51:11-13,28, Warach,S., 2002

The Risk-Benefit Profile of Commonly Used Herbal Therapies: Ginkgo, St. John's Wort, Genseng, Echinacea, Saw Palmetto, and Kava
Ann Int Med 136:42-53, Ernst,E., 2002

Magnetic Resonance Imaging in Basilar Artery Occlusion
Arch Neurol 59:398-402, du Mesnil de Rochemont,R.,et al, 2002

Stroke Prevention Therapy Beyond Antithrombotics: Unifying Mechanisms in Ischemic Stroke Pathogenesis and Implications for Therapy
Stroke 33:862-875, Gorelick,P.B., 2002

Predictors of Hemorrhagic Transformation in Patients Receiving Intra-Arterial Thrombolysis
Stroke 33:717-724, Kidwell,C.S.,et al, 2002

The Neurological Masquerade of Intravascular Lymphomatosis
Arch Neurol 59:439-443, Beristain,X.&Azzarelli,B., 2002

Recent Developments in Neurology
BMJ 324:656-660, Wiebe,S.,&Nicolle,M.W., 2002

A Multicenter Study of Treatment of Primary CNS Lymphoma
Neurol 58:1513-1520, Ferreri,A.J.M.,et al, 2002

Acute Dystonic Reactions to "Street Xanax"
NEJM 346:1753, Hendrickson,R.G.,et al, 2002

First-line Therapy with Temozolomide Induces Regression of Primary CNS Lymphoma
Neurol 58:1573-1574, Herrlinger,U.,et al, 2002

Changes in Blood Flow and Oxygen Metabolism During Visual Stimulation in Carotid Artery Disease
Stroke 33:1294-1300, Yamauchi,H.,et al, 2002

Global Cerebral Edema After Subarachnoid Hemorrhage
Stroke 33:1225-1232, Claasen,J.,et al, 2002

Acute Basilar Artery Occlusion Treated with Combined Intravenous Abciximab and Intra-arterial Tissue Plaminogen Activator
Stroke 33:1424-1427, Eckert,B.,et al, 2002

Thrombolytic Therapy Within 3 to 6 Hours After Onset of Ischemic Stroke
Stroke 33:1437-1441, Ringleb,P.A.,et al, 2002

Statins and Risk of Polyneuropathy
Neurol 58:1333-1337,1321, Gaist,D.,et al, 2002

Paraneoplastic Chorea Associated with CRMP-5 Neuronal Antibody and Lung Carcinoma
Ann Neurol 51:625-630, Vernino,S.,et al, 2002

Brown-Sequard Syndrome After Esophageal Sclerotherapy and Crack Cocaine Abuse
Neurol 58:1129-1130, Mueller,D. &Gilden,D.H., 2002